NAFLD and NASH are associated with substantial metabolic stress and inflammation, mediated by IL6/STAT3 signaling, that affects both cell survival and determine an increased risk of developing hepatocellular carcinoma3,6,22. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.